iBio (company)

iBio (company)

A biotechnology company that develops and markets pharmaceutical products. It was founded in 2008 and is located in New York City.

iBio is a United States-based biotechnology company with a focus on streamlining the process of making a pharmaceutical product available on the market. It has developed platforms and has manufacturing facilities in Texas which can develop and product medical solutions such as vaccines, biotherapeutics, diagnostic products, and some medical devices.

COVID-19

The company's platform called FastPharming uses technology to expedite the development process for making medical solutions, such as the one necessary for COVID-19 due to the pandemic is has caused. iBio partnered with the Infectious Disease Research Institute (IDRI) to develop a vaccine where the company is set to provide process development and manufacturing services to IDRI, which is in charge of the pre-clinical development of the vaccine and clinical studies overview.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
iBio, Inc. funding round, February 2016
2,177,000
February 2016
3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Tom Isett

CEO

Further reading

Title
Author
Link
Type
Date

IBio Expands COVID-19 Vaccine Collaboration - Contract Pharma

Web

iBio Joins the Alliance for Biosecurity

Web

March 20, 2020

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.